Skip to content

Formilation and Investigation Serrata gel in Treatment:A Randomized Prallel Controlled Clinical trail

Formilation and Investigation Serrata gel in Treatment:A Randomized Prallel Controlled Clinical trail

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220427054669N1
Enrollment
60
Registered
2022-11-21
Start date
2022-11-06
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoids. Hemorrhoids (bleeding) without prolapse outside of anal canal AND Hemorrhoids (bleeding) that prolapse with straining, but retract spontaneously

Interventions

Intervention 1: In the intervention group, a mixture containing Boswellia seratta gel is used topically once a night and routine care is performed. Intervention 2: Control group: The control group w

Sponsors

Orogen Sina daru
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: having informed consent of the patient First and second degree hemorrhoids Internal and external hemorrhoid no systematic diseases

Exclusion criteria

Exclusion criteria: Patients with anal fistula Patients with grade 3 and 4 hemorrhoids with a doctor's diagnosis Patients who need non-local treatment according to the doctor's diagnosis

Design outcomes

Primary

MeasureTime frame
Reduction of symptoms such as (itching, bleeding, swelling and protrusion). Timepoint: Symptoms will be assessed on days 7, 14, 21, and 30 days after treatment. Method of measurement: ?Data will be collected using a questionnaire (HDSS).;The impact of hemorrhoids on daily life and quality of life. Timepoint: Once at the beginning of the study (before the intervention) and the second time on the 30th day of the study. Method of measurement: With a questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Fatemeh Heydarpour

Kermanshah University of Medical Sciences

FATEMEH_HYDARPUR@yahoo.com+98 83 3427 6473

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026